Roche CEO: Bullish About U.S. Pharmaceutical Market

The transcript covers a discussion with Roche's CEO about the company's optimism for the US market, their investments, and the impact of healthcare policies on drug pricing and affordability. It also touches on FDA streamlining, diversity in hiring, and updates on drug development and clinical trials. The CEO emphasizes the importance of innovation and maintaining a diverse workforce, while also addressing the performance of Roche's diabetes unit.

How does Roche ensure access to their medicines for all American citizens?

What is Roche's stance on the FDA's efforts to streamline drug approval processes?

What challenges does Roche face in the diabetes care segment, and how do they plan to address them?